UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 98

Sortiert nach

Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study

British journal of cancer, 2017-06, Vol.116 (12), p.1520-1525

2017

Volltextzugriff (PDF)

Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study

World journal of urology, 2019-12, Vol.37 (12), p.2631-2637

2019

Volltextzugriff (PDF)

Short-Course Versus Split-Course Radiotherapy in Metastatic Spinal Cord Compression: Results of a Phase III, Randomized, Multicenter Trial

Journal of clinical oncology, 2005-05, Vol.23 (15), p.3358-3365

2005

Volltextzugriff (PDF)

Radiotherapy-induced nausea and vomiting (RINV): MASCC/ESMO guideline for antiemetics in radiotherapy: update 2009

Supportive care in cancer, 2011-03, Vol.19 (Suppl 1), p.5-14

2011

Volltextzugriff (PDF)

Twelve-year results of LINAC-based radiosurgery for vestibular schwannomas

Strahlentherapie und Onkologie, 2020, Vol.196 (1), p.40-47

2020

Volltextzugriff (PDF)

Upfront metastasis-directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance

Medical oncology (Northwood, London, England), 2021-06, Vol.38 (6), p.72, Article 72

2021

Volltextzugriff (PDF)

Long-term outcome of moderate hypofractionated stereotactic radiotherapy for meningiomas

Strahlentherapie und Onkologie, 2015-12, Vol.191 (12), p.953-960

2015

Volltextzugriff (PDF)

Reliability of algebraic sum to evaluate adjuvant pelvic radiotherapy and vaginal cuff brachytherapy cumulative doses in uterine cancers

Journal of contemporary brachytherapy, 2022-10, Vol.14 (5), p.470-475

2022

Volltextzugriff (PDF)

Definitive three-dimensional high-dose-rate brachytherapy for inoperable endometrial cancer

Journal of contemporary brachytherapy, 2017-04, Vol.9 (2), p.118-123

2017

Volltextzugriff (PDF)

A predictive model of polymetastatic disease from a multicenter large retrospectIve database on colorectal lung metastases treated with stereotactic ablative radiotherapy: The RED LaIT-SABR study

Clinical and translational radiation oncology, 2023-03, Vol.39, p.100568-100568, Article 100568

2023

Volltextzugriff (PDF)

Tumor Relapse or Radionecrosis After Radiosurgery: Single-Photon Emission Computed Tomography for Differential Diagnosis. In Regard to Blonigen et al. Irradiated Volume as a Predictor of Brain Radionecrosis After Linear Accelerator Stereotactic Radiosurgery. ( Int J Radiat Oncol Biol Phys 2010;77:996–1001)

International journal of radiation oncology, biology, physics, 2010-11, Vol.78 (4), p.1279-1279

2010

Volltextzugriff (PDF)

A prospective phase II trial on reirradiation of brain metastases with radiosurgery

Clinical and translational radiation oncology, 2019-07, Vol.17, p.1-6

2019

Volltextzugriff (PDF)

International Patterns of Practice in the Management of Radiation Therapy-induced Nausea and Vomiting

International journal of radiation oncology, biology, physics, 2012-09, Vol.84 (1), p.e49-e60

2012

Volltextzugriff (PDF)

Be Careful in Getting Cost-Effectiveness Conclusions From a Debatable Trial

International journal of radiation oncology, biology, physics, 2007-05, Vol.68 (1), p.314-314

2007

Volltextzugriff (PDF)

Prevention and Treatment of Bone Metastases in Breast Cancer

Journal of clinical medicine, 2013-09, Vol.2 (3), p.151-175

2013

Volltextzugriff (PDF)

Correction: Ripamonti, C.; Trippa, F.; Barone, G.; Maranzano, E. Prevention and Treatment of Bone Metastases in Breast Cancer. J. Clin. Med. 2013, 2, 151–175

Journal of clinical medicine, 2015-12, Vol.4 (12), p.1998-1998

2015

Volltextzugriff (PDF)

Randomized, Multicenter, Phase IIB Study of Preoperative Chemoradiotherapy in T3 Mid-Distal Rectal Cancer: Raltitrexed + Oxaliplatin + Radiotherapy Versus Cisplatin + 5-Fluorouracil + Radiotherapy

International journal of radiation oncology, biology, physics, 2008-02, Vol.70 (2), p.403-412

2008

Volltextzugriff (PDF)

2023 Updated MASCC/ESMO Consensus Recommendations: prevention of radiotherapy- and chemoradiotherapy-induced nausea and vomiting

Supportive care in cancer, 2024-01, Vol.32 (1), p.26-26, Article 26

2024

Volltextzugriff (PDF)

STereotactic Ablative RadioTherapy in NEWly Diagnosed and Recurrent Locally Advanced Non-Small Cell Lung Cancer Patients Unfit for ConcurrEnt RAdio-Chemotherapy: Early Analysis of the START-NEW-ERA Non-Randomised Phase II Trial

International journal of radiation oncology, biology, physics, 2023-03, Vol.115 (4), p.886-896

2023

Volltextzugriff (PDF)

1 – 25 von 98

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(92)
Mit Volltextzugriff
(94)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(85)
Science & Technology
(85)
Oncology
(69)
Humans
(67)
Middle Aged
(42)
Male
(41)
Female
(39)
Aged
(35)
Radiology, Nuclear Medicine & Medical Imaging
(34)
Radiotherapy
(34)
Adult
(30)
Aged, 80 And Over
(20)
Medicine
(17)
Medicine & Public Health
(17)
Radiation Therapy
(15)
Radiosurgery
(14)
Retrospective Studies
(13)
Treatment Outcome
(13)
Chemotherapy
(12)
Prospective Studies
(12)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study

Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study

Re-irradiation for recurrent glioma: outcome evaluation, toxicity and prognostic factors assessment. A multicenter study of the Radiation Oncology Italian Association (AIRO)

Palliative radiotherapy indications during the COVID-19 pandemic and in future complex logistic settings: the NORMALITY model

Short-Course Versus Split-Course Radiotherapy in Metastatic Spinal Cord Compression: Results of a Phase III, Randomized, Multicenter Trial

Radiotherapy-induced nausea and vomiting (RINV): MASCC/ESMO guideline for antiemetics in radiotherapy: update 2009

Twelve-year results of LINAC-based radiosurgery for vestibular schwannomas

Upfront metastasis-directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance

Pain REduction with bone metastases STereotactic radiotherapy (PREST): A phase III randomized multicentric trial

Long-term outcome of moderate hypofractionated stereotactic radiotherapy for meningiomas

Reliability of algebraic sum to evaluate adjuvant pelvic radiotherapy and vaginal cuff brachytherapy cumulative doses in uterine cancers

Definitive three-dimensional high-dose-rate brachytherapy for inoperable endometrial cancer

A predictive model of polymetastatic disease from a multicenter large retrospectIve database on colorectal lung metastases treated with stereotactic ablative radiotherapy: The RED LaIT-SABR study

A prospective phase II trial on reirradiation of brain metastases with radiosurgery

International Patterns of Practice in the Management of Radiation Therapy-induced Nausea and Vomiting

Be Careful in Getting Cost-Effectiveness Conclusions From a Debatable Trial

Prevention and Treatment of Bone Metastases in Breast Cancer

Correction: Ripamonti, C.; Trippa, F.; Barone, G.; Maranzano, E. Prevention and Treatment of Bone Metastases in Breast Cancer. J. Clin. Med. 2013, 2, 151–175

Randomized, Multicenter, Phase IIB Study of Preoperative Chemoradiotherapy in T3 Mid-Distal Rectal Cancer: Raltitrexed + Oxaliplatin + Radiotherapy Versus Cisplatin + 5-Fluorouracil + Radiotherapy

2023 Updated MASCC/ESMO Consensus Recommendations: prevention of radiotherapy- and chemoradiotherapy-induced nausea and vomiting

STereotactic Ablative RadioTherapy in NEWly Diagnosed and Recurrent Locally Advanced Non-Small Cell Lung Cancer Patients Unfit for ConcurrEnt RAdio-Chemotherapy: Early Analysis of the START-NEW-ERA Non-Randomised Phase II Trial

Metastasis-directed Therapy in Treating Nodal Oligorecurrent Prostate Cancer: A Multi-institutional Analysis Comparing the Outcome and Toxicity of Stereotactic Body Radiotherapy and Elective Nodal Radiotherapy

A Large, Multicenter, Retrospective Study on Efficacy and Safety of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups

Immunotherapy in association with stereotactic radiotherapy for non-small cell lung cancer brain metastases: results from a multicentric retrospective study on behalf of AIRO

Suchergebnisse filtern